高效的HBV囊组合调节器 (CAMs) 的合成和评估
Franck Amblard1, Zhe Chen1, John Wiseman1
1Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, and Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Bioorganic chemistry
|October 23, 2023
概括
新的HBV囊组合调节器 (CAMs) 为慢性乙型肝炎治疗提供了希望. 化合物10a显示强大的抗HBV活性和有利的毒性,可能改善受这种肝脏感染影响的数百万人的结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 慢性乙型肝炎病毒 (HBV) 感染影响全球超过2.9亿人,导致显著的死亡率.
- 目前的治疗方法,包括核糖类类似物和基化干扰素,治愈率低,大多数患者需要终身治疗.
- 肝炎病毒的共价闭环DNA (cccDNA) 对于病毒的持久性至关重要,使其成为新疗法的关键标.
研究的目的:
- 发现具有强大的抗病毒活性的新型HBV囊组装调节器 (CAMs).
- 确定可以有效降低HBVccDNA水平的化合物.
- 确定新发现的HBV CAMs的安全性和药理学概况.
主要方法:
- 结构-活性关系 (SAR) 研究围绕主要的HBV CAM,GLP-26进行.
- 从SAR研究中获得的新型化合物的合成和体外评估.
- 对化合物10a的毒性和细胞药理学的全面评估.
主要成果:
- 发现了一种非有毒的化合物,被指定为10a,具有亚纳米抗HBV活性.
- 化合物10a显示出有前途的细胞药理学和高级毒性概况.
- SAR研究成功优化了HBV CAMs的核心结构.
结论:
- HBV CAMs代表了慢性乙型肝炎的有前途的新治疗策略.
- 化合物10a具有作为一种新型抗HBV药物的显著潜力.
- 进一步开发HBV CAM可能会导致改善治疗选择,并可能治愈慢性HBV感染.
关键词:
抗病毒药物是一种抗病毒药.在CAE CAE中.在这里,我们可以看到CAM,CAM,CAM.药物 药物 药物 药物 药物肝炎病毒的囊体肝炎是一种肝炎.里托纳维尔 (Ritonavir) 是一种药物.小分子是小分子.病毒 病毒 病毒更多相关视频
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.8K
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
相关概念视频
02:41Protein Complex Assembly
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...